Literature DB >> 350252

The use of dobutamine in myocardial infarction for reversal of the cardiodepressive effect of metoprolol.

F Waagstein, I Malek, A C Hjalmarson.   

Abstract

1 Ten patients with acute myocardial infarction were infused dobutamine in increasing doses up to 15 microgram kg--1 min--1. 2 Metoprolol (total dose 15 mg) was then given intravenously to nine of these patients and the beta-adrenoceptor against effects produced by dobutamine were effectively reversed. 3 Nine patients with acute myocardial infarction pretreated with metoprolol (15 mg) were infused dobutamine 15 microgram kg--1 min--1 for 10 min. This resulted in effective reversal of the beta-adrenoceptor antagonist effects induced by metoprolol, without the occurrence of serious arrhythmias or other unwanted effects. 4 Dobutamine may be valuable in counteracting any undesirable cardiodepressive effects of beta-adrenergic receptor blocking drugs (especially the cardioselective agents) in patients with acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350252      PMCID: PMC1429366          DOI: 10.1111/j.1365-2125.1978.tb01666.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  THE EFFECT OF DESLANOSIDE ON THE DURATION OF THE PHASES OF VENTRICULAR SYSTOLE IN MAN.

Authors:  A M WEISSLER; A R KAMEN; R S BORNSTEIN; C D SCHOENFELD; S COHEN
Journal:  Am J Cardiol       Date:  1965-02       Impact factor: 2.778

2.  The importance of blood resistivity in the measurement of cardiac output by the thoracic impedance method.

Authors:  D W Hill; F D Thompson
Journal:  Med Biol Eng       Date:  1975-03

3.  The effect of haematocrit on the resistivity of human blood at 37 degrees C and 100 kHz.

Authors:  D W Hill; F D Thompson
Journal:  Med Biol Eng       Date:  1975-03

4.  Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction.

Authors:  F Waagstein; A C Hjalmarson
Journal:  Acta Med Scand Suppl       Date:  1976

5.  Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics.

Authors:  H S Mueller; S M Ayres; A Religa; R G Evans
Journal:  Circulation       Date:  1974-06       Impact factor: 29.690

6.  Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol.

Authors:  F Waagstein; A C Hjalmarson; H S Wasir
Journal:  Br Heart J       Date:  1974-11

7.  Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.

Authors:  D Jewitt; J Birkhead; A Mitchell; C Dollery
Journal:  Lancet       Date:  1974-08-17       Impact factor: 79.321

8.  Evaluation of the pre-ejection period as an estimate of myocardial contractility in dogs.

Authors:  R C Talley; J F Meyer; J L McNay
Journal:  Am J Cardiol       Date:  1971-04       Impact factor: 2.778

Review 9.  Special article. The role of beta-adrenergic blockade in myocardial infarction.

Authors:  D E Jewitt; B N Singh
Journal:  Prog Cardiovasc Dis       Date:  1974 Jan-Feb       Impact factor: 8.194

10.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

View more
  2 in total

1.  Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.

Authors:  R Ariniego; F Waagstein; B Mombay; A Hjalmarson
Journal:  Br Heart J       Date:  1979-08

2.  Prospective, randomized trial comparing fluids and dobutamine optimization of oxygen delivery in high-risk surgical patients [ISRCTN42445141].

Authors:  Suzana M Lobo; Francisco R Lobo; Carlos A Polachini; Daniela S Patini; Adriana E Yamamoto; Neymar E de Oliveira; Patricia Serrano; Helder S Sanches; Marco A Spegiorin; Marcio M Queiroz; Antonio C Christiano; Elisangela F Savieiro; Paula A Alvarez; Silvia P Teixeira; Geni S Cunrath
Journal:  Crit Care       Date:  2006-05-12       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.